Stepan Q3 net income falls 54% to $10.8M; adjusted EBITDA up 6%, dividend raised

STEPAN CO

2025-Q3 EPS reported $1.83 revenue$1,778,228,000

Q3 net income $10.8M (-54% YoY); adjusted EPS $0.48 vs $1.03; revenue $590.3M (+8% on higher prices/mix).
Adj. EBITDA $56.2M (+6%); free cash flow $40.2M; Surfactants adj. EBITDA -14% on Pasadena start-up costs.
Polymers volume +8%; Specialty Products adj. EBITDA +113% on pharma order timing; Consumer demand soft.
Quarterly dividend raised $0.01 to $0.395/share, marking 58th consecutive annual increase, payable Dec 15.
Management reaffirms full-year adjusted EBITDA growth; Philippines asset sale on track to close in Q4.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.